CODEXIS
Codexis, Inc. is an industrial biotechnology company that specializes in engineers enzymes for pharmaceutical and chemical production through biocatalysis. Codexis’ technologies enable scale-up and implementation of biocatalytic solutions to optimize process development, from research to manufacturing. There are currently over 50 pharmaceutical firms using Codexis’ technology, products and services in their manufacturing process development. Codexis creates its products by applying its CodeEvolver® directed evolution technology platform, which introduces genetic mutations into microorganisms. Codexis, Inc. began operations as an independent company in 2002, and became a publicly traded company in 2009. They are located in Redwood City, CA USA
CODEXIS
Industry:
Biotechnology Chemical Sustainability
Founded:
2002-01-01
Address:
Redwood City, California, United States
Country:
United States
Website Url:
http://www.codexis.com
Total Employee:
51+
Status:
Active
Contact:
650-421-8100
Email Addresses:
[email protected]
Total Funding:
162 M USD
Technology used in webpage:
IPv6 ASP.NET Amazon S3 Microsoft Java EE Apple Whitelist Amazon Oregon Region Amazon Frankfurt Region Entrust EV Entrust SSL
Similar Organizations
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Casdin Capital
Casdin Capital investment in Post-IPO Equity - Codexis
Pequot Capital
Pequot Capital investment in Series D - Codexis
CMEA Capital
CMEA Capital investment in Series D - Codexis
EDBI
EDBI investment in Series D - Codexis
Chevron Technology Ventures
Chevron Technology Ventures investment in Series D - Codexis
Maxygen
Maxygen investment in Series D - Codexis
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-03-29 | seqWell | Codexis investment in Series C - seqWell | 7 M USD |
| 2022-03-15 | Molecular Assemblies | Codexis investment in Series B - Molecular Assemblies | 25.8 M USD |
| 2021-04-15 | Molecular Assemblies | Codexis investment in Series A - Molecular Assemblies | 11.8 M USD |
Newest Events participated
Key Employee Changes
| Date | New article |
|---|---|
| 2022-07-18 | Codexis Announces CEO Transition Effective August 9, 2022 |
| 2021-11-15 | Codexis Appoints Two New Senior Leaders for Human Resources and Corporate Development |
Official Site Inspections
http://www.codexis.com Semrush global rank: 1.1 M Semrush visits lastest month: 29.7 K
- Host name: ec2-54-208-101-55.compute-1.amazonaws.com
- IP address: 54.208.101.55
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
More informations about "Codexis"
Codexis - Crunchbase Company Profile & Funding
Codexis is a biosciences company applying synthetic chemistry technologies to create improved versions of small molecule therapeutics.See details»
Codexis - Wikipedia
Codexis uses directed evolution to develop its enzymes. Using this method, scientists genetically engineer genes, then screen the enzymes produced to see if it creates the properties needed for a specific reaction. Their protein engineering platform, called CodeEvolver, uses machine learning and high-throughput experimentation to learn protein sequence changes and their impacts on protein function. See details»
About Codexis | Our culture & vision :: Codexis, Inc.
Codexis is a leading enzyme engineering company and biosolutions supplier. We design and develop enzymes to improve the health of people and the planet.See details»
Org Chart Codexis - The Official Board
The org chart of Codexis contains its 15 main executives including Stephen Dilly, Georgia Erbez and Kevin Norrett.See details»
Codexis - The Org
Codexis, Inc. is a leading protein engineering company applying innovative technologies to Unlock the Power of Proteinsâ„¢.See details»
Our People :: Codexis, Inc. (CDXS)
Meet the Team Codexis is grounded in two decades of experience, resilience and agility and have engineered enzymes that have enabled some of the world’s most celebrated pharmaceutical …See details»
Codexis - Funding, Financials, Valuation & Investors
Codexis is a biosciences company applying synthetic chemistry technologies to create improved versions of small molecule therapeutics.See details»
Codexis Company Profile - Office Locations, Competitors, Revenue ...
Oct 29, 2024 Codexis has 5 employees at their 1 location and $70.14 m in annual revenue in FY 2023. See insights on Codexis including office locations, competitors, revenue, financials, …See details»
CEO and Executive Team - The Org
The executive team at Codexis has a history of being Advisory Board Members, Board of Directors Members, and Chief Financial Officers.See details»
Jobs at Codexis Inc | Codexis Inc Careers
At Codexis, we engineer enzymes for biosolutions that benefit human health and environmental health. From developing biocatalysts for sustainable pharmaceutical manufacturing, to …See details»
Corporate Governance :: Codexis, Inc. (CDXS)
As a retired CFO of DataStax, Inc. and previously as executive vice president and CFO of Fusion-io Multisystems and MySQL AB, Dennis Wolf brings significant experience in financial …See details»
Codexis, Inc. - Drug pipelines, Patents, Clinical trials - Patsnap
Explore Codexis, Inc. with its drug pipeline, therapeutic area, technology platform, 2 clinical trials, 109 news, and 119 literature, Disease Domain:Endocrinology and ...See details»
Stephen Dilly - President & CEO at Codexis | The Org
Stephen Dilly is President & CEO of Codexis since August 2022, Stephen brings more than three decades of executive management experience in the biopharmaceutical industry.See details»
Codexis Announces New Employment Inducement Grants
1 day ago REDWOOD CITY, Calif., Dec. 06, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable …See details»
Codexis Announces Enhanced Strategic Focus and Extends …
Jul 20, 2023 Organization Streamlined to Focus on Continued Advancement and Commercialization of ECO Synthesisâ„¢ Platform for RNAi Therapeutics Production Codexis …See details»
Culture :: Codexis, Inc. (CDXS)
Codexis strives to play a positive role by fostering a culture that promotes employee volunteering to support the communities in which we work and live. We participate in multiple initiatives …See details»
Codexis to Participate in Upcoming Healthcare Conferences
Nov 4, 2024 Codexis is a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver ® technology platform …See details»
Codexis (CDXS) Earnings Date and Reports 2024 - MarketBeat
Nov 27, 2024 When is Codexis' next earnings announcement? View the latest CDXS earnings date, analysts forecasts, earnings history, and conference call transcripts.See details»
Contact :: Codexis, Inc. (CDXS)
Contact Codexis for inquiries about our capabilities and productsSee details»
Codexis Announces New Employment Inducement Grants
1 day ago Codexis is a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver ® technology platform …See details»